Nav: Home

Kidney-resident macrophages -- a role for healing during acute kidney injury?

January 24, 2019

BIRMINGHAM, Ala. - During development in the womb, immune cells called macrophages go to the kidneys, and they remain there for life. Understanding the possible healing role for these macrophages after kidney damage may be crucial to helping treat patients who suffer acute kidney injury.

Acute kidney injury, or AKI, is a devastating condition that develops in two-thirds of critically ill patients, and patients with AKI have a 60 percent risk of dying. In AKI, kidneys can become scarred and can show progressive decline in function, becoming unable to heal their tissue.

In a JCI Insight study published today, University of Alabama at Birmingham researchers have found that, during AKI in a mouse model, the kidney-resident macrophages are reprogrammed to a developmental state, resembling these same cells when they are found in newborn mice. Newborn mouse kidneys are still developing. This reprogramming during AKI may be important to promote healing and tissue regeneration. If a similar developmental shift is seen for human kidney-resident macrophages during AKI, that could aid new therapeutic approaches for patients.

The experimental challenge in this study was distinguishing the kidney-resident macrophages from the many cells that invade the kidney from blood circulation in response to kidney damage. Some of these invading cell types can differentiate into macrophages and dendritic cells in the kidney, and it was unknown whether some of the invaders become kidney-resident macrophages.

The UAB researchers used parabiosis -- the linking of the blood circulatory systems between two mice -- to reveal whether the kidney-resident macrophages after AKI were from invading precursors or from renewal by existing kidney-resident macrophages in the kidney.

In the parabiosis experiments, two mice shared blood circulation for four weeks, and then one underwent ischemia/reperfusion-induced AKI. Because the immune cells of the two mice have different surface markers that identify which mouse they come from, researchers could follow the invasion of the AKI kidneys by circulating immune cells from the healthy mouse. They found that the infiltrating cells contributed only minimally to the kidney-resident macrophage cell pool in the damaged kidneys.

Thus, after kidney injury, the kidney-resident macrophages are a distinct cellular subpopulation that does not differentiate from nonresident, infiltrating, precursor immune cells.

Researchers, led by co-senior authors Anupam Agarwal, M.D., director of the Division of Nephrology in the UAB Department of Medicine, and James George, Ph.D., professor in the UAB Department of Surgery, detailed how the kidney-resident macrophages are reprogrammed to a developmental state after injury. In response to the disease model, the kidney-resident macrophages turned off their expression of major histocompatibility complex type II, or MHCII. This lack of expression is similar to kidney-resident macrophages in newborn mice -- those mice, the researchers showed, lack expression of this protein up to postnatal day seven, and then begin to express it over the next two weeks. Notably, MHCII protein and macrophages have important roles in autoimmunity and transplant rejection.

In addition, kidney-resident macrophages after AKI underwent transcriptional reprogramming to express a gene profile closely resembling that of the kidney-resident macrophages in newborn mice at postnatal day seven. Further supporting their role in development and healing, the reprogrammed kidney-resident macrophages were enriched in Wnt signaling, an active pathway that is vital for mouse and human kidney development.

Co-first authors of the JCI Insight study, "Resident macrophages reprogram toward a developmental state after acute kidney injury," are Jeremie M. Lever and Travis D. Hull, M.D., Ph.D., who are trainees from the NIH-funded UAB Medical Scientist Training Program, an M.D., Ph.D. program.

"Macrophage biology has reached a pivotal point," said Lever, a UAB graduate student and NIH F31 individual fellow. Many basic science research studies have suggested the importance for tissue-resident macrophages in healing after injury, but development of therapies promoting them is still in early stages, Lever says. "In order to successfully utilize these cells for contemporary translational interventions, I believe we will need to be specific about the origin -- tissue-resident versus infiltrative -- of the cells we plan to target."

Hull, now a surgery resident at Massachusetts General Hospital in Boston, said, "This work demonstrates that tissue resident macrophages possess the same plasticity that has been demonstrated in other immunological cell types. Moreover, this ability to reprogram to an early ontological phenotype is a potential avenue for therapeutic intervention, if the cellular signals and mechanisms of this reprogramming can be fully elucidated.

"This is an exciting development in the field of acute kidney injury," Hull said, "but also may represent a therapeutic target in fields such as transplantation, where the importance of macrophage biology is less well understood."
Other co-authors are Ravindra Boddu, Laurence M. Black, Oreoluwa O. Adedoyin, Zhengqin Yang, Amie M. Traylor, Yanlin Jiang, Jacelyn E. Peabody, Hannah E. Eckenrode, Subhashini Bolisetty and Michal Mrug, UAB Department of Medicine; Mark E. Pepin and Adam R. Wende, UAB Department of Pathology; Zhang Li, Kurt A. Zimmerman and Bradley K. Yoder, UAB Department of Cellular, Developmental and Integrative Biology; and David K. Crossman and Michael R. Crowley, UAB Department of Genetics.

This work was supported by National Institute of Diabetes and Digestive and Kidney Diseases grants DK59600, DK115752, DK097423, DK115169, DK116672 and DK103931, and also the core resource of the UAB-UCSD O'Brien Center for AKI Research, DK079337. Additional support came from the Office of Research and Development, Medical Research Service, Department of Veterans Affairs grant BX00229; the Polycystic Kidney Disease Research Foundation grant 214G16A; the UAB School of Medicine AMC21; and the UAB Medical Scientist Training Program grant GM008361.

At UAB, Agarwal holds the Marie S. Ingalls Endowed Chair in Nephrology Leadership, and George holds the UAB Cardiovascular Surgical Research Chair.

University of Alabama at Birmingham

Related Immune Cells Articles:

Identification of new populations of immune cells in the lungs
In an article published in Nature Communications, the Immunophysiology Laboratory of the GIGA Institute, headed by Prof.
A genomic barcode tracker for immune cells
A new research method to pinpoint the immune cells that recognise cancer could significantly change how we treat the disease.
Scientists reminded immune cells on what side they should be
International group of scientists in the joint study of the laboratory of the Wistar Institute, University of Pittsburgh and I.M.
Dead cells disrupt how immune cells respond to wounds and patrol for infection
Immune cells prioritise the clearance of dead cells overriding their normal migration to sites of injury.
Study gives new perspective on production of blood cells and immune cells
A new study provides a thorough accounting of blood cell production from hematopoietic stem cells.
Gut immune cells play by their own rules
Only a few vaccines -- for example, against polio and rotavirus -- can be given orally.
Revealed: How the 'Iron Man' of immune cells helps T cells fight infection
The immune system's killer T cells are crucial in fighting viral infections.
A bad influence: the interplay between tumor cells and immune cells
Research at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) yielded new insights into the environment surrounding different types of lung tumors, and described how these complex cell ecosystems may in turn ultimately affect response to treatment.
Immune cells help older muscles heal like new
The immune system's macrophage cells are critical to growing muscle tissues in a lab, say the biomedical engineers at Duke University who earlier reported the world's first self-healing lab-grown muscles.
How damaging immune cells develop during tuberculosis
Insights into how harmful white blood cells form during tuberculosis infection point to novel targets for pharmacological interventions, according to a study published in the open-access journal PLOS Pathogens by Valentina Guerrini and Maria Laura Gennaro of Rutgers New Jersey Medical School, and colleagues.
More Immune Cells News and Immune Cells Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#538 Nobels and Astrophysics
This week we start with this year's physics Nobel Prize awarded to Jim Peebles, Michel Mayor, and Didier Queloz and finish with a discussion of the Nobel Prizes as a way to award and highlight important science. Are they still relevant? When science breakthroughs are built on the backs of hundreds -- and sometimes thousands -- of people's hard work, how do you pick just three to highlight? Join host Rachelle Saunders and astrophysicist, author, and science communicator Ethan Siegel for their chat about astrophysics and Nobel Prizes.